Youxue Zhang

Harbin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer.

iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer.

Journal: Nanoscale

Published: December 12, 2025

Thermosensitive hydrogel-enhanced RPA-CRISPR/Cas12a biosensor for ultrasensitive detection of methylated loci in breast cancer ctDNA.

Thermosensitive hydrogel-enhanced RPA-CRISPR/Cas12a biosensor for ultrasensitive detection of methylated loci in breast cancer ctDNA.

Journal: Analytica chimica acta

Published: December 04, 2025

Tetrastigma Hemsleyanum Polysaccharide Suppresses Triple-Negative Breast Cancer by Disrupting the Hippo-YAP/TEAD4-PDIA4 Axis and Endoplasmic Reticulum Stress Adaptation.

Tetrastigma Hemsleyanum Polysaccharide Suppresses Triple-Negative Breast Cancer by Disrupting the Hippo-YAP/TEAD4-PDIA4 Axis and Endoplasmic Reticulum Stress Adaptation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 27, 2025

CSF1R inhibitors mitigate CDK4/6 inhibitor-induced immunosuppression to increase antitumor immunity in HR+/HER2- breast cancer.

CSF1R inhibitors mitigate CDK4/6 inhibitor-induced immunosuppression to increase antitumor immunity in HR+/HER2- breast cancer.

Journal: Oncogene

Published: August 01, 2025

LncRNA LINC00667 inhibits breast cancer progression by regulating POTEE to suppress mitochondrial oxidative phosphorylation.

LncRNA LINC00667 inhibits breast cancer progression by regulating POTEE to suppress mitochondrial oxidative phosphorylation.

Journal: Cellular signalling

Published: June 11, 2025

Engineered crRNA Drives RPA-T7-CRISPR/Cas14a Cascade for Ultrasensitive Detection of ctDNA PIK3CA H1047R.

Engineered crRNA Drives RPA-T7-CRISPR/Cas14a Cascade for Ultrasensitive Detection of ctDNA PIK3CA H1047R.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 20, 2025

Comprehensive analysis of the biological functions and prognostic significance of GDI1 in breast cancer.

Comprehensive analysis of the biological functions and prognostic significance of GDI1 in breast cancer.

Journal: Medicine

Published: April 17, 2025

Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.

Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.

Journal: Cancer research

Published: February 10, 2025

Physical Encapsulation and Chemotherapy: A Synergistic Hydrogel Strategy for Tumor Suppression.

Physical Encapsulation and Chemotherapy: A Synergistic Hydrogel Strategy for Tumor Suppression.

Journal: Advanced healthcare materials

Published: January 29, 2025

An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing.

An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing.

Journal: Cancer medicine

Published: March 14, 2024

Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer.

Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer.

Journal: NPJ precision oncology

Published: January 24, 2024

Single-cell RNA sequencing reveals small extracellular vesicles derived from malignant cells that contribute to angiogenesis in human breast cancers.

Single-cell RNA sequencing reveals small extracellular vesicles derived from malignant cells that contribute to angiogenesis in human breast cancers.

Journal: Journal of translational medicine

Published: May 06, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026